We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+1.48%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$218B
AUM Growth
+$27.7B
(+15%)
Cap. Flow
+$35.3B
Cap. Flow
% of AUM
16.16%
Top 10 Holdings %
Top 10 Hldgs %
11.23%
Holding
3,840
New
278
Increased
2,380
Reduced
985
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.58B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
Costco
COST
|
+$680M |
| 4 |
Booking.com
BKNG
|
+$647M |
| 5 |
Broadcom
AVGO
|
+$559M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$355M |
| 2 |
Walmart Inc
WMT
|
+$348M |
| 3 |
Zoom
ZM
|
+$321M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
Lyft
LYFT
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.29% |
| 2 | Financials | 14.55% |
| 3 | Industrials | 13.75% |
| 4 | Consumer Discretionary | 11.6% |
| 5 | Healthcare | 11.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Definitive Healthcare
DH
$70.4M
| $863K | ﹤0.01% |
702,023
+138,336
| +25% | +$240K |
|
|
ESPR
2852
DELISTED
Esperion Therapeutics
ESPR
| $863K | ﹤0.01% |
314,866
+24,352
| +8% | +$77.1K |
|
2853
MoonLake Immunotherapeutics
MLTX
$1.49B
| $861K | ﹤0.01% |
46,185
+13,299
| +40% | +$220K |
|
2854
Vanguard California Tax-Exempt Bond ETF
VTEC
$2.8B
| $860K | ﹤0.01% |
8,685
-596
| -6% | -$60K |
|
2855
CAE Inc. Common Shares
CAE
$8.62B
| $860K | ﹤0.01% |
33,199
-8,878
| -21% | -$269K |
|
|
SLDE
2856
Slide Insurance Holdings
SLDE
$2.42B
| $860K | ﹤0.01% |
47,788
+179
| +0.4% | +$3.13K |
|
2857
iShares Core US REIT ETF
USRT
$4.66B
| $860K | ﹤0.01% |
14,526
-1,244
| -8% | -$74.7K |
|
2858
Spire Global
SPIR
$499M
| $859K | ﹤0.01% |
68,293
+57,031
| +506% | +$609K |
|
2859
Fidelity Value Factor ETF
FVAL
$1.37B
| $859K | ﹤0.01% |
12,379
+3,023
| +32% | +$219K |
|
2860
MaxCyte
MXCT
$115M
| $858K | ﹤0.01% |
1,221,182
+1,127,208
| +1,199% | +$1.05M |
|
2861
Standard BioTools
LAB
$307M
| $858K | ﹤0.01% |
933,098
+513,545
| +122% | +$622K |
|
2862
SoundThinking
SSTI
$102M
| $855K | ﹤0.01% |
129,142
+114,613
| +789% | +$838K |
|
2863
Vanguard Materials ETF
VAW
$3.11B
| $854K | ﹤0.01% |
3,790
+2,005
| +112% | +$459K |
|
2864
Esquire Financial Holdings
ESQ
$1.14B
| $852K | ﹤0.01% |
7,929
+63
| +0.8% | +$6.74K |
|
2865
CVRx
CVRX
$148M
| $850K | ﹤0.01% |
+89,904
| New | +$658K |
|
2866
Cambria Foreign Shareholder Yield ETF
FYLD
$710M
| $846K | ﹤0.01% |
22,657
+15,188
| +203% | +$545K |
|
|
SKYT
2867
DELISTED
SkyWater Technology
SKYT
| $845K | ﹤0.01% |
30,846
-14,709
| -32% | -$432K |
|
2868
Astrana Health
ASTH
$1.78B
| $843K | ﹤0.01% |
34,379
+7,152
| +26% | +$169K |
|
2869
Capital Group Core Equity ETF
CGUS
$11.8B
| $837K | ﹤0.01% |
21,785
+442
| +2% | +$17.8K |
|
|
MAZE
2870
Maze Therapeutics
MAZE
$1.54B
| $834K | ﹤0.01% |
27,945
+506
| +2% | +$22.3K |
|
2871
VictoryShares US Small Mid Cap Value Momentum ETF
USVM
$1.8B
| $832K | ﹤0.01% |
8,786
+3,415
| +64% | +$329K |
|
2872
BlackSky Technology
BKSY
$1.03B
| $829K | ﹤0.01% |
32,951
+2,563
| +8% | +$61.2K |
|
|
FEGE
2873
First Eagle Global Equity ETF
FEGE
$2.31B
| $828K | ﹤0.01% |
17,623
+6,096
| +53% | +$297K |
|
2874
Schwab International Small-Cap Equity ETF
SCHC
$5.59B
| $828K | ﹤0.01% |
17,713
+12,567
| +244% | +$608K |
|
2875
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
| $827K | ﹤0.01% |
+7,995
| New | +$823K |
|
Similar funds
VGA
AQR Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, AQR Capital Management held 3,840 positions worth $218B, up 15% from $191B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
AQR Capital Management deployed $35.3B of net new capital in Q1 2026, opening 278 new positions and adding to 2,380 existing holdings. Its largest new stake was Versant Media Group: 5,801,568 shares worth $211M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Atlassian, an estimated $355M trimmed.
- AQR Capital Management's largest Q1 2026 buy was Versant Media Group: 5,801,568 shares worth $211M.
- AQR Capital Management added most to Microsoft in Q1 2026, an estimated $1.58B increase.
- AQR Capital Management's biggest Q1 2026 reduction was Atlassian, cutting an estimated $355M.
- AQR Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $226M.
- AQR Capital Management's ten largest holdings make up 11% of its $218B portfolio in Q1 2026.
- AQR Capital Management opened 278 new positions and closed 101 in Q1 2026.
- AQR Capital Management's portfolio value rose 15% quarter-over-quarter to $218B.
Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.